a year ago
MRNA
AnalystsMani ForooharMani Foroohar's Stock Forecasts
AnalystsMani Foroohar
Sectors:
Analyst Ranking
Bottom 1%
#4216 out of 4237 analysts
Average Return
-14.69%
Win Rate
47%43 out of 91
Risk vs Reward
Poor
Good
Mani Foroohar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rocket Pharmaceuticals IncRCKT | +104.86% | $10.70 | $21.92 | 2022-05-20 - 2023-05-19 | Buy |
Amryt Pharma PLCAMYT | +104.65% | $7.09 | $14.51 | 2022-03-10 - 2023-01-09 | Buy |
Bridgebio Pharma IncBBIO | +104.18% | $6.70 | $13.68 | 2022-05-06 - 2023-05-05 | Buy |
Amryt Pharma PLCAMYT | +101.53% | $7.20 | $14.51 | 2022-06-24 - 2023-01-09 | Buy |
Mirum Pharmaceuticals IncMIRM | +100.27% | $14.70 | $29.44 | 2021-08-06 - 2022-08-05 | Buy |
Mani Foroohar Analyst Color
Get additional color on Mani Foroohar's coverage of popular stocks
Mani Foroohar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | 10 | Hold | $40.00 | +10.96% | Downgrades | 24 days ago |
Allovir IncALVR | 8 | Buy | $19.00 | +379.80% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 11 | Buy | $27.00 | +89.34% | Maintains | 2 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Hold | $13.00 | -29.19% | Maintains | 2 months ago |
Decibel Therapeutics IncDBTX | 5 | Hold | $2.00 | -52.27% | Downgrades | 3 months ago |
Moderna IncMRNA | 16 | Sell | $93.00 | -28.74% | Downgrades | 3 months ago |
Ionis Pharmaceuticals IncIONS | 11 | Hold | $27.00 | -35.33% | Maintains | 3 months ago |
Recursion Pharmaceuticals IncRXRX | 6 | Hold | $8.00 | -2.79% | Maintains | 4 months ago |
Regenxbio IncRGNX | 6 | Hold | $14.00 | -29.01% | Maintains | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 9 | Buy | $49.00 | +124.36% | Maintains | 4 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $84.00 | +105.08% | Maintains | 4 months ago |
Editas Medicine IncEDIT | 4 | Hold | $7.00 | -27.61% | Maintains | 4 months ago |
Bluebird Bio IncBLUE | 7 | Hold | $8.00 | +120.39% | Maintains | 4 months ago |
Beam Therapeutics IncBEAM | 2 | Buy | $77.00 | +126.27% | Maintains | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 8 | Hold | $143.00 | -26.16% | Maintains | 4 months ago |
Mirum Pharmaceuticals IncMIRM | 9 | Buy | $39.00 | +48.12% | Maintains | 5 months ago |
Amryt Pharma PLCAMYT | 6 | Hold | $14.50 | -1.36% | Downgrades | 5 months ago |
Graphite Bio IncGRPH | 4 | Hold | $2.00 | -32.66% | Downgrades | 5 months ago |
Wave Life Sciences LtdWVE | 3 | Hold | $7.00 | +53.85% | Maintains | 6 months ago |
Abeona Therapeutics IncABEO | 5 | Hold | $6.00 | +81.27% | Maintains | 7 months ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $76.00 | +16.92% | Maintains | 7 months ago |
Talaris Therapeutics IncTALS | 5 | Hold | $2.00 | -20.95% | Maintains | 7 months ago |
Caribou Biosciences IncCRBU | 4 | Buy | $34.00 | N/A | Maintains | a year ago |
Sio Gene Therapies IncSIOX | 2 | Hold | $1.00 | N/A | Downgrades | a year ago |
Dicerna Pharmaceuticals IncDRNA | 4 | Buy | $47.00 | N/A | Maintains | 2 years ago |
Adverum Biotechnologies IncADVM | 5 | Hold | $2.00 | N/A | Maintains | 2 years ago |
Avrobio IncAVRO | 1 | Hold | $10.00 | N/A | Maintains | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.